Federal Register of Legislation - Australian Government

Primary content

PB 20 of 2023 Determinations/Health as made
This instrument amends the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 by adding various forms, not brands of warfarin that are currently subject to a Therapeutic Goods Administration (TGA) Serious Scarcity Substitution Instrument (SSSI). This allows supplies made under the TGA SSSI to be PBS subsidised.
Administered by: Health and Aged Care
Registered 16 Mar 2023
Tabling HistoryDate
Tabled HR20-Mar-2023
Tabled Senate21-Mar-2023
To be repealed 20 Jun 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Help with file formats Help with file formats
Legislative Instrument
F2023L00235 : Authoritative PDF Document : 0.7MB Primary Document Icon F2023L00235 : ZIP Document : 76KB
6 pages

Explanatory Statement
F2023L00235ES : PDF Document : 0.6MB Primary Document Icon F2023L00235ES : ZIP Document : 25KB
6 pages